Literature DB >> 7426257

Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery.

J G Bovill, P S Sebel.   

Abstract

The pharmacokinetics following a bolus injection of fentanyl 60 micrograms kg-1 as the sole anaesthetic in five patients undergoing cardiac surgery are described. Before cardiopulmonary bypass the kinetics can be described by a biexponential decay curve with an initial half-life of 1.7 +/- 0.85 min and a half-life during the tissue uptake phase of 69 +/- 8.2 min. Two patients had secondary peaks in plasma fentanyl concentration during the first 5 min after injection. After 5 min cardiopulmonary bypass with haemodilution, the fentanyl concentration decreased by an average of 53%. The half-life in the post-bypass elimination phase was 423 +/- 36.9 min. No second peaks during the elimination phase were found.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426257     DOI: 10.1093/bja/52.8.795

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  23 in total

Review 1.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

2.  Epidural meperidine analgesia after cardiac surgery.

Authors:  R J Robinson; S Brister; E Jones; M Quigly
Journal:  Can Anaesth Soc J       Date:  1986-09

Review 3.  The pharmacokinetic behaviour of opioids administered during cardiac surgery.

Authors:  R Hall
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

Review 4.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

5.  Sufentanil disposition during cardiopulmonary bypass.

Authors:  P Flezzani; M J Alvis; J R Jacobs; M M Schilling; S Bai; J G Reves
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

Review 6.  Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.

Authors:  J Scholz; M Steinfath; M Schulz
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

7.  The influence of chronic preoperative propranolol therapy on cardiovascular dynamics and narcotic requirements during operation in patients with coronary artery disease.

Authors:  T H Stanley; S de Lange; M J Boscoe; N de Bruijn
Journal:  Can Anaesth Soc J       Date:  1982-07

Review 8.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

9.  The influence of hypothermia on the disposition of fentanyl--human and animal studies.

Authors:  G Koren; C Barker; G Goresky; D Bohn; G Kent; J Klein; S M MacLeod; W D Biggar
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Authors:  Evelien J M Kuip; Maarten L Zandvliet; Stijn L W Koolen; Ron H J Mathijssen; Carin C D van der Rijt
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.